Polymorphisms in folate-related genes: Association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia

2008-09-18

Leukemia , Volume 22 - Issue 9 p. 1798- 1800

Additional Metadata
Keywords	5, 10 methylenetetrahydrofolate reductase (FADH2), DNA polymorphism, acute lymphoblastic leukemia, article, cancer chemotherapy, child, childhood leukemia, clinical protocol, continuous infusion, controlled study, cytarabine, data analysis, drug megadose, folate metabolism, folic acid, folinic acid, genotype, glycine hydroxymethyltransferase, human, infection, liver toxicity, major clinical study, methionine synthase, methotrexate, methylenetetrahydrofolate dehydrogenase, mucosa inflammation, multiple cycle treatment, patient coding, prednisolone, priority journal, reduced folate carrier, repeated drug dose, retrospective study, side effect, skin toxicity
Persistent URL	doi.org/10.1038/leu.2008.66, hdl.handle.net/1765/15146
Journal	Leukemia
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Huang, L., Tissing, W., de Jonge, R., van Zelst, B., & Pieters, R. (2008). Polymorphisms in folate-related genes: Association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia, 22(9), 1798–1800. doi:10.1038/leu.2008.66

Publication